Potomac Analytics' Logo

Broker-Dealers on SEC Form D for AEGIS CAPITAL CORP.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 151-160 out of 180 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series DNA I175692001/08/2019D/A$12,500,000$5,312,000
AEGIS CAPITAL CORP.15007Scilex Pharmaceuticals Inc.160354208/04/2014D/A$5,250,000$5,001,700
AEGIS CAPITAL CORP.15007Outstanding Foods, Inc.179076807/09/2020D/A$5,000,000$5,000,000
AEGIS CAPITAL CORP.15007Aquyre Biosciences Inc188737705/13/2022D/A$5,000,000$4,999,995
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503702/01/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503703/13/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503703/15/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503704/04/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Shopoff Opportunity Fund VI, L.P.174503704/18/2019D/A$100,000,000$4,409,737
AEGIS CAPITAL CORP.15007Helocyte, Inc.167980811/04/2016D/A$5,000,000$3,998,000

180 Results

Display: